{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:01:39Z","timestamp":1746417699891,"version":"3.40.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Taishan Scholars Program of Shandong Province","award":["tsqn201909148"],"award-info":[{"award-number":["tsqn201909148"]}]},{"name":"Shandong Province Key R&D Program","award":["2020CXGC010902"],"award-info":[{"award-number":["2020CXGC010902"]}]},{"name":"Planning Research Project of Philosophy and Social Science of Shandong Province","award":["21CTYJ19"],"award-info":[{"award-number":["21CTYJ19"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Oncogenic microRNAs, a kind of stable epigenetic inhibitors, often deregulated in Mycosis fungoides (MF) which affect the skin and tend to transform and spread.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Previous studies investigating the de-expression of microRNA in MF patients skin biopsies identified that they were not only regulated by signaling pathway, but also regulated other signaling pathway. Furthermore, studies have elucidated the molecular mechanisms of the STAT signaling pathway that can promote a great diversity of miRNA expression via cytokine binding receptors, activating Janus kinase-3 and STAT proteins. But some non-STAT signaling pathway with mircoRNA de-expression in MF was incomplete.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Taken together, these studies demonstrate that microRNA may be used as the prognosis, progression and diagnose of MF, as they can not only control MF cell proliferation, but also induce MF cell apoptosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029248","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:06:01Z","timestamp":1656331561000},"page":"e29248","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNAs and their signaling pathway in mycosis fungoides"],"prefix":"10.1097","volume":"101","author":[{"given":"Zhiyuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-4554","authenticated-orcid":false,"given":"Xuewen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijrobp.2008.06.1918","article-title":"Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas","volume":"74","author":"Neelis","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","article-title":"TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/apm.12186","article-title":"miRNA in mycosis fungoides and skin inflammation","volume":"121","author":"Persson","year":"2013","journal-title":"Apmis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA expression profiling of mycosis fungoides","volume":"5","author":"van Kester","year":"2011","journal-title":"Mol Oncol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3892\/etm.2015.2443","article-title":"Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction","volume":"10","author":"Jiang","year":"2015","journal-title":"Exp Ther Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/mco.2015.560","article-title":"Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring","volume":"3","author":"Jia","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"R11-20250504","first-page":"1146","article-title":"Diagnostic findings in adenomyosis: a pictorial review on the major concerns","volume":"19","author":"Graziano","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/jdv.12571","article-title":"Early changes in miRNA expression are predictive of response to extracorporeal photopheresis in cutaneous T-cell lymphoma","volume":"29","author":"McGirt","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.18632\/oncotarget.4111","article-title":"Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma","volume":"6","author":"Sibbesen","year":"2015","journal-title":"Oncotarget"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e29541","DOI":"10.1371\/journal.pone.0029541","article-title":"miR-122 regulates p53\/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma","volume":"7","author":"Manfe","year":"2012","journal-title":"Plos One"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00403-016-1698-8","article-title":"CD164 identifies CD4(+) T cells highly expressing genes associated with malignancy in Sezary syndrome: the Sezary signature genes, FCRL3, Tox, and miR-214","volume":"309","author":"Benoit","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/ijms18102136","article-title":"Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas","volume":"18","author":"Dusilkova","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3109\/10428194.2013.815352","article-title":"Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas","volume":"55","author":"Marstrand","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4161\/cbt.12.12.18144","article-title":"The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma","volume":"12","author":"Abraham","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4161\/15384101.2014.947759","article-title":"Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines","volume":"13","author":"Litvinov","year":"2014","journal-title":"Cell Cycle"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1159\/000430303","article-title":"MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1","volume":"36","author":"Yang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"O\u2019Connell","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br J Haematol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jid.2018.03.1526","article-title":"SATB1 in Malignant T Cells","volume":"138","author":"Fredholm","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/bjd.15422","article-title":"Oncogenic role of microRNA-155 in mycosis fungoides: an in vitro and xenograft mouse model study","volume":"177","author":"Moyal","year":"2017","journal-title":"Br J Dermatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"45730","DOI":"10.18632\/oncotarget.10160","article-title":"STAT5 induces miR-21 expression in cutaneous T cell lymphoma","volume":"7","author":"Lindahl","year":"2016","journal-title":"Oncotarget"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome","volume":"131","author":"van der Fits","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1182\/blood-2014-05-571778","article-title":"Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma","volume":"125","author":"Huang","year":"2015","journal-title":"Blood"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/jid.2013.461","article-title":"miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides\/cutaneous T-cell lymphoma","volume":"134","author":"McGirt","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jid.2019.01.033","article-title":"Preclinical targeting of MicroRNA-214 in cutaneous T-cell lymphoma","volume":"139","author":"Kohnken","year":"2019","journal-title":"J Invest Dermatol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.1007\/s13277-016-5325-2","article-title":"Aberrant microRNA expression in tumor mycosis fungoides","volume":"37","author":"Papadavid","year":"2016","journal-title":"Tumour Biol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.humpath.2006.10.021","article-title":"Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sezary syndrome and role of the bmi-1 and Ras oncogenes in disease progression","volume":"38","author":"Zhang","year":"2007","journal-title":"Hum Pathol"},{"key":"R34-20250504","first-page":"1433","article-title":"Implication of the Ras and myc oncoproteins in the pathogenesis of mycosis fungoides","volume":"11","author":"Tosca","year":"1991","journal-title":"Anticancer Res"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/onc.2015.435","article-title":"MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas","volume":"35","author":"Kitadate","year":"2016","journal-title":"Oncogene"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/15384101.2019.1629789","article-title":"miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway","volume":"18","author":"Xia","year":"2019","journal-title":"Cell Cycle"},{"key":"R37-20250504","first-page":"7207","article-title":"MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma","volume":"34","author":"Ralfkiaer","year":"2014","journal-title":"Anticancer Res"},{"key":"R38-20250504","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-06-788950","article-title":"Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study","volume":"131","author":"Lindahl","year":"2018","journal-title":"Blood"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jid.2018.03.1500","article-title":"MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma","volume":"138","author":"Shen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000505743","article-title":"MicroRNA-93 targets p21 and promotes proliferation in mycosis fungoides T cells","volume":"237","author":"Gluud","year":"2021","journal-title":"Dermatology"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/exd.14124","article-title":"Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation","volume":"30","author":"Rittig","year":"2021","journal-title":"Exp Dermatol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"adv00270","DOI":"10.2340\/00015555-3574","article-title":"MicroRNA-106b regulates expression of the tumour suppressors p21 and TXNIP and promotes tumour cell proliferation in mycosis fungoides","volume":"100","author":"Lindahl","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.18632\/oncotarget.13810","article-title":"Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma","volume":"8","author":"Abe","year":"2017","journal-title":"Oncotarget"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.1007\/s13277-016-5259-8","article-title":"Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides","volume":"37","author":"Garaicoa","year":"2016","journal-title":"Tumour Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:01:13Z","timestamp":1746331273000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":44,"journal-issue":{"issue":"25","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029248","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"2021-09-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}